Работы, на которые ссылается эта работа
Работ: 257
Работа: Eurasian guidelines for the prevention and treatment of cardiovascular diseases in patients with obesity (2022)
2019 ESC Guidelines for the diagnosis and management of chronic coronary syndromes
Juhani Knuuti, William Wijns, Antti Saraste +83
Статья2019Цитирований: 13ABIGeneral Cardiovascular Risk Profile for Use in Primary Care
Ralph B. D’Agostino, Ramachandran S. Vasan, Michael Pencina +4
Статья2008Цитирований: 6ABIEuropean Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts) * Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR)
Authors/Task Force Members:, Joep Perk, Guy De Backer +82
Статья2012Цитирований: 6ABIAngiotensin–Neprilysin Inhibition versus Enalapril in Heart Failure
John J.V. McMurray, Milton Packer, Akshay S. Desai +8
Статья2014Цитирований: 5ABICardiovascular and Renal Outcomes with Empagliflozin in Heart Failure
Milton Packer, Stefan D. Anker, Javed Butler +36
Статья2020Цитирований: 4ABIEplerenone in Patients with Systolic Heart Failure and Mild Symptoms
Faı̈ez Zannad, John J.V. McMurray, Henry Krum +6
Статья2010Цитирований: 4ABIContributory Risk and Management of Comorbidities of Hypertension, Obesity, Diabetes Mellitus, Hyperlipidemia, and Metabolic Syndrome in Chronic Heart Failure: A Scientific Statement From the American Heart Association
Biykem Bozkurt, David Aguilar, Anita Deswal +9
Обзорная статья2016Цитирований: 4ABIBlood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis
Dena Ettehad, Connor A. Emdin, Amit Kiran +6
Обзорная статья2015Цитирований: 3ABIEffects of blood pressure-lowering on outcome incidence in hypertension
Costas Thomopoulos, Gianfranco Parati, Alberto Zanchetti
Обзорная статья2015Цитирований: 3ABIDapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
John J.V. McMurray, Scott D. Solomon, Silvio E. Inzucchi +35
Статья2019Цитирований: 3ABIObesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association
Tiffany M. Powell‐Wiley, Paul Poirier, Lora E. Burke +8
Обзорная статья2021Цитирований: 3ABIObesity and the Obesity Paradox in Heart Failure
Tamara B. Horwich, Gregg C. Fonarow, Adrienne L. Clark
Обзорная статья2018Цитирований: 3ABICardiovascular Effects of Intensive Lifestyle Intervention in Type 2 Diabetes
Статья2013Цитирований: 3ABICardiac PET Imaging for the Detection and Monitoring of Coronary Artery Disease and Microvascular Health
Thomas H. Schindler, Heinrich R. Schelbert, Alessandra Quercioli +1
Обзорная статья2010Цитирований: 3ABICardiovascular Risk After Bariatric Surgery for Obesity
John A. Batsis, Michael G. Sarr, Maria L. Collazo–Clavell +4
Обзорная статья2008Цитирований: 3ABICombination Therapy Versus Monotherapy in Reducing Blood Pressure: Meta-analysis on 11,000 Participants from 42 Trials
David S Wald, Malcolm Law, Joan K. Morris +2
Обзорная статья2009Цитирований: 3ABIEffect of Aging and Physical Activity on Left Ventricular Compliance
Armin Arbab‐Zadeh, Erika Dijk, Anand Prasad +6
Статья2004Цитирований: 3ABIThe Implications of Obesity for Cardiac Arrhythmia Mechanisms and Management
Rajeev K. Pathak, Rajiv Mahajan, Dennis H. Lau +1
Обзорная статья2014Цитирований: 3ABI